News Daily News Apixaban Provides ‘Intermediate-Value’ Care, New Economic Analysis Shows Michael O'Riordan March 31, 2017
News Conference News ACC 2017 RE-CIRCUIT: Doubts Over Dabigatran for A-fib Ablations Put to Rest Yael L. Maxwell March 20, 2017
News Daily News NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease Todd Neale March 14, 2017
News Conference News ACC 2017 Does Hormone Replacement Therapy Curb Atherosclerosis? New Imaging Study Opens Old Questions Shelley Wood March 09, 2017
News Daily News Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS Todd Neale February 08, 2017
News Conference News ISET 2017 Patient Follow-up After Pulmonary Embolism Critical for Better Care, Understanding of Disease Caitlin E. Cox February 08, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2017 Caitlin E. Cox February 01, 2017
News Features Coalition of the Willing: PERTs Aim to Disentangle ‘Gordian Knot’ of Acute Pulmonary Embolism Todd Neale January 02, 2017
News Daily News Patients With A-fib Still Have High Mortality Risk After Appropriate Anticoagulation Is Started Todd Neale December 05, 2016
News Conference News AHA 2016 Misdosing NOACs Common in Everyday Practice, With Implications for Stroke and Bleeding Shelley Wood November 21, 2016
News Conference News AHA 2016 Errar la Dosis de NOAC en la Práctica Clínica Diaria es algo Habitual, lo cual tiene Implicaciones en Materia de ACV y Hemorragias Shelley Wood November 21, 2016
News Conference News AHA 2016 Subclinical A-fib Common in Older, Asymptomatic Patients Todd Neale November 18, 2016
News Conference News AHA 2016 La FA Subclínica es Común en Pacientes Asintomáticos de Mayor Edad Todd Neale November 18, 2016
News Daily News Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians Caitlin E. Cox November 17, 2016
News Daily News Las Dudas en torno al Equilibrio Riesgos-Beneficios para los Filtros VCI Siguen Irritando a los Médicos Caitlin E. Cox November 17, 2016
News Conference News AHA 2016 Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results Todd Neale November 15, 2016
News Daily News Según los Investigadores, Contemplar de Embolismo Pulmonar por Síncope Inexplicado es ‘Absolutamente Obligatorio.’ Michael O'Riordan October 24, 2016
News Daily News Considering Pulmonary Embolism for Unexplained Syncope Is ‘Absolutely Mandatory,’ Investigators Say Michael O'Riordan October 24, 2016
News Daily News FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm Michael O'Riordan October 11, 2016